Tuesday, May 29, 2018 • 13:00 - 14:30
Track 4 - DRUGS IN THE ED
Track Chair: Dr. Peter Zed
Uses of Ketamine in the ED - Dr. Gary Andolfatto
Description: The ED use of ketamine for various indications will be discussed, including analgesia, sedation, and behavioural control.
- Understand indications and contraindications to ketamine use
- Understand the differential effects of ketamine based on dosing
- Understand practical strategies for use of ketamine in common important scenarios
- Ketamine is a versatile drug that can be used for a wide variety of indications
- Ketamine can be given by various routes
- Ketamine effects are predictable through the targeting of dosage
Biography: Attending Physician and ED Research Director at Lions Gate Hospital in North Vancouver. Interests include improvements and new directions in sedation and analgesia
The Top 5 Therapeutic Papers in Emergency Medicine for 2017-18 - Dr. Kirk Magee
Description: The presentation will present the top 5 therapeutics in the ED papers and discuss their implications to everyday Emergency Medicine practice.
- Identify the top 5 therapeutic papers in the past year relevant to the practice of EM.
- Critically appraise the top 5 therapeutic papers.
- Apply the evidence from the top 5 therapeutic papers to the practice of Emergency Medicine.
Biography: He graduated from Dalhousie Medical School before completing residency training and a Masters degree at the University of Alberta. He returned home to Nova Scotia in 2001 and is currently the Research Director and Interim Head at the Dalhousie Department of Emergency Medicine. He spends his free time with his wife and eight year old son at the rink during hockey season and on the water in the summer.
Adverse Drug-Related ED Visits: How Big Is the Problem? - Dr. Peter Zed
Description: In the era of increased attention to overall patient safety, several interventions have been implemented to attempt to reduce medication misadventure in both the community and hospital setting. However, patients continue to experience adverse drug events (ADEs) which are associated with significant morbidity and mortality and result in many ED visits. This session will outline the impact of ADEs in Canada and discuss the overall burden on our health-care system. Patient populations at risk and the drugs/drug classes most commonly associated with ADEs will also be discussed. The session will include numerous case studies illustrating the issues and discuss how many of these events could have been prevented. Finally, strategies and future directions will be outlined to describe how we can identify and prevent ADEs.
- To discuss the overall health care and ED impact of adverse drug events
- To discuss factors associated with identifying patients at risk and drug classes
- To discuss strategies we can utilize in the ED to identify, manage and prevent adverse drug events.
- Adverse drug events account for approximately 10% of all ED visits
- 50-70% of all adverse drug events are preventable
- Strategies to prevent adverse drug events are complex and often take time and require further study
Biography: Dr. Peter J. Zed completed a Bachelor of Science in Chemistry (Dalhousie University), Bachelor of Science in Pharmacy (Memorial University of Newfoundland), pharmacy practice residency with the Royal Columbian Hospital, and Doctor of Pharmacy (The University of British Columbia). He is currently Professor and Associate Dean, Practice Innovation, Faculty of Pharmaceutical Sciences, Associate Member, Department of Emergency Medicine, Faculty of Medicine at UBC and Pharmacotherapeutics Specialist in Emergency Medicine at Vancouver General Hospital. He has sustained a productive research program for both clinical and practice-based research with a consistent record of extra-mural funding. He has over 100 peer-reviewed publications and over 130 conference research abstracts and has been the recipient of many research, teaching and service awards.